ArticleScientific reports2022

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma.

Jun Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.